Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.

Georgia KarageorgiouKonstantina ChronopoulouIlias GeorgalasStylianos A KandarakisIoannis TservakisPetros Petrou

Published in: European journal of ophthalmology (2022)

The present case descibes the occurrence of BRVO soon after the vaccination with the Oxford-AstraZeneca vaccine. The close temporal relationship between the BRVO incidence and the vaccination is reinforced by the lack of othe subjective cause to justify the episode.

Keyphrases

risk assessment
optical coherence tomography
risk factors
diabetic retinopathy
depressive symptoms